Update on Evaluation and Nonsurgical Treatment Strategies for the Symptomatic Patient with HCM - 2015 AHA Symposium, Part 1

HCM, an unexplained hypertrophy not due to some other secondary cause, is a highly variable disease that presents uniquely in each patient. For this reason it is important to understand different evaluation and treatment strategies that need to be carefully tailored to each patient.

Richard G. Bach, MD, FACC, FAHA
Director, Hypertrophic Cardiomyopathy Center
Washington University School of Medicine

View Full Profile

Visit the following links for more videos from the 2015 AHA Symposium:

Part 2: Preventing Sudden Cardiac Death in HCM

Part 3: Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy

Part 4: New Approaches to the Surgical Management of Hypertrophic Obstructive Cardiomyopathy

Part 5: What Clinicians Need to Know About Genetic Testing for Patients and Families with HCM

Related Videos